
Human umbilical cord stem cell derived MSC exosomes.
Two research products, one standard: cGMP-manufactured in an FDA-registered U.S. facility to Section 351(a) biologics standards, batch-tested by independent laboratories (Eurofins and/or ZenBio), and labelled with a batch / lot number so every unit traces back to its Certificate of Analysis. Supplied to licensed physicians, clinics and researchers for research use only.
Research Use OnlyHuman Umbilical Cord Stem Cell Derived MSC Exosomes
100 Billion exosomes · 5 mL sterile saline vial
Physician-administered MSC-derived exosomes in sterile saline, cGMP-manufactured in an FDA-registered U.S. facility, independently batch-tested by Eurofins and/or ZenBio, and released with a per-lot Certificate of Analysis. Every label carries a batch / lot number so each vial traces back to its COA.
- 100 Billion exosomes per 5 mL vial, in sterile saline
- Human umbilical cord (Wharton's Jelly) MSC source — screened, ethically sourced
- cGMP-manufactured in an FDA-registered U.S. facility
- Every batch independently tested by Eurofins and/or ZenBio — Certificate of Analysis per lot, batch / lot number on every label
- Quality program held to Section 351(a) biologics standards (PHS Act)
- Shipped cold-chain to licensed practitioners and research clinics
How physicians and research clinics administer the vials, under their own protocols and clinical judgment.

Systemic infusion in sterile saline under physician supervision.

Targeted delivery to joints, tendons and soft tissue.

Inhaled delivery studied in respiratory and lung research.

Topical ophthalmic delivery explored in eye and retinal research.
Where it is being researched
Physicians and research clinics across the U.S. use BioRegenEx material in these research areas. Each link opens our overview of what the published work explores.
Published studies on MSC exosomes by injection, infusion, inhalation and ophthalmic delivery
- Injection of human umbilical cord mesenchymal stem cells exosomes for the treatment of knee osteoarthritis: from preclinical to clinical research
- Combined intrathecal and intravenous exosome injection efficiency in a multiple sclerosis patient: a case report
- Treatment of severe traumatic brain injury with human bone marrow mesenchymal stem cell extracellular vesicles: a case report
- Efficacy of topical mesenchymal stem cell exosome in Sjögren's syndrome-related dry eye: a randomized clinical trial
Research Use OnlyHuman Umbilical Cord Stem Cell Derived MSC Exosome Hydrogel
100 Billion / 15 mL · 200 Billion / 30 mL
A professional topical exosome gel formulated with MSC-derived exosomes, cytokines and growth factors. Stable at room temperature for up to 18 months, with a batch / lot number on every unit.
- 100 Billion exosomes — 15 mL
- 200 Billion exosomes — 30 mL
- Stable at room temperature for up to 18 months
- Formulated with MSC-derived exosomes, cytokines and growth factors
- Every batch independently tested by Eurofins and/or ZenBio; batch / lot number on every unit, COA on request
Professional topical applications in aesthetic, dermatology and wound-care practices.
Where it is being researched
Physicians and research clinics across the U.S. use BioRegenEx material in these research areas. Each link opens our overview of what the published work explores.
Published studies on topical MSC exosomes in skin, wound and hair research
- Adipose Mesenchymal Stem Cell-Derived Exosomes Versus Platelet-Rich Plasma Treatment for Photoaged Facial Skin: An Investigator-Blinded, Split-Face, Non-Inferiority Trial
- Autologous Micrografts Containing Nanovesicles, Exosomes, and Follicle Stem Cells in Androgenetic Alopecia: In Vitro and In Vivo Analysis Through a Multicentric, Observational, Evaluator-Blinded Study
- The transforming role of wharton's jelly mesenchymal stem cell-derived exosomes for diabetic foot ulcer healing: a randomized controlled clinical trial
- Exosomes and Signaling Nanovesicles from the Nanofiltration of Preconditioned Adipose Tissue with Skin-B(®) in Tissue Regeneration and Antiaging: A Clinical Study and Case Report
Supplied with proof.
What stands behind every vial and every tube — from the cleanroom to the Certificate of Analysis in your hand.

Made in an FDA-registered U.S. facility
Every lot is produced under cGMP-aligned processes, held to Section 351(a) biologics standards, and released only after identity, concentration, sterility and endotoxin testing.

Tested by Eurofins and/or ZenBio, every batch
Independent laboratories test every batch; the batch / lot number printed on each label traces back to its own Certificate of Analysis and characterization data.

Inspected, then shipped cold-chain
Vials are inspected before release and shipped cold-chain to licensed practitioners and research clinics nationwide.
Request supply & documentation.
Physicians, clinics, and researchers partner with us for characterized, documented MSC exosomes — supplied for research use only.
